Exchange: NASDAQ·Updated 10:37 AM EDT
BTAI logo

BTAI BioXcel Therapeutics Inc

$0.132
$0.0308
(18.92%)
Today
Reported EarningsMay 15
Mkt Cap$5.1M
Vol5M

About BTAI

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
22

Extremely Bearish Sentiment

How do you feel about BTAI?

Advertisement|Remove ads.